A clinical study of amlodipine besilate OD tablet for the essential hypertension patients - Comparative study on the antihypertensive effect and the safety between a bland drug and a generic drug
Not Applicable
- Conditions
- Essential hypertension
- Registration Number
- JPRN-UMIN000002144
- Lead Sponsor
- agano Kidney Evaluation Association (NKEA)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who take calcium channel blocker except amlodipine besilate regular tablets 2.Grade III hypertension 3.Secondary hypertension 4.Malignant hypertension 5.Patients with hepatic dysfunction or severe hepatic disease 6.Patients with a past history of hypersensitiveness to the study drug 7.Pregnant, lactating, and probably pregnant patients, and patients who want to become pregnant during the study period 8.Patients with malignant cancer 9.Patients with a past history of drug abuse or drug addiction 10.Patients who have attended toany clinical trials within 12 months before the start of the administration, etc
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of diastolic blood pressure from baseline in trough and sitting position
- Secondary Outcome Measures
Name Time Method